financetom
Business
financetom
/
Business
/
Viatris' Q1 Adjusted Earnings, Revenue Decrease; 2024 Outlook Reduced
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viatris' Q1 Adjusted Earnings, Revenue Decrease; 2024 Outlook Reduced
May 9, 2024 4:59 AM

07:30 AM EDT, 05/09/2024 (MT Newswires) -- Viatris ( VTRS ) reported Q1 adjusted earnings Thursday of $0.67 per diluted share, down from $0.77 a year earlier.

Analysts polled by Capital IQ expected $0.67.

Total revenue for the quarter ended March 31 was $3.66 billion, compared with $3.73 billion a year earlier.

Analysts surveyed by Capital IQ expected $3.69 billion.

The company reduced its full-year 2024 adjusted earnings guidance to $2.66 to $2.81 per diluted share, from $2.70 to $2.85. Analysts polled by Capital IQ expect $2.74.

The company also cut its revenue outlook for the year to $14.98 billion to $15.48 billion, from $15.25 billion to $15.75 billion. Analysts surveyed by Capital IQ expect $15.19 billion.

Price: 11.80, Change: -0.01, Percent Change: -0.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ASE Technology Reports 6.7% Increase in Revenue for October
ASE Technology Reports 6.7% Increase in Revenue for October
Nov 10, 2025
03:59 AM EST, 11/10/2025 (MT Newswires) -- ASE Technology ( ASX ) reported Monday revenue of 60.23 billion New Taiwan dollars ($1.94 billion) for October, up 6.7% from a year earlier. Assembly, testing, and material revenue for the month increased 22.9% year over year to NT$36.04 billion, the company said. ...
Diagnostic imaging services provider RadNet's Q3 revenue up 13.4%
Diagnostic imaging services provider RadNet's Q3 revenue up 13.4%
Nov 10, 2025
Overview * RadNet ( RDNT ) Q3 revenue grows 13.4% yr/yr to $522.9 mln * Adjusted EPS for Q3 misses analyst expectations * Company revises full-year guidance upwards for revenue and EBITDA Outlook * RadNet ( RDNT ) raises 2025 Imaging Center revenue guidance to $1.9 bln-$1.93 bln * Company increases 2025 Imaging Center adjusted EBITDA guidance to $276 mln-$284...
Monro Insider Bought Shares Worth $11,102,374, According to a Recent SEC Filing
Monro Insider Bought Shares Worth $11,102,374, According to a Recent SEC Filing
Nov 10, 2025
03:58 AM EST, 11/10/2025 (MT Newswires) -- Carl C Icahn, 10% Owner, on November 05, 2025, executed a purchase for 638,659 shares in Monro ( MNRO ) for $11,102,374. Following the Form 4 filing with the SEC, Icahn has control over a total of 5,078,573 common shares of the company, with 5,078,573 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/876427/000153949725002873/xslF345X05/ownership.xml ...
BridgeBio Pharma Insider Sold Shares Worth $3,888,999, According to a Recent SEC Filing
BridgeBio Pharma Insider Sold Shares Worth $3,888,999, According to a Recent SEC Filing
Nov 10, 2025
03:59 AM EST, 11/10/2025 (MT Newswires) -- Ronald J Daniels, Director, on November 06, 2025, sold 61,031 shares in BridgeBio Pharma ( BBIO ) for $3,888,999. Following the Form 4 filing with the SEC, Daniels has control over a total of 16,991 common shares of the company, with 16,991 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1743881/000147083125000297/xslF345X05/wk-form4_1762556613.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved